newsfilter
← Latest News
GlobeNewswire·

Hillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

Company Hosted its R&D Day to Discuss Product and Pipeline Goals Across 4 Pipeline Candidates and its Quatramer™ Tumor-Targeting Platform; Multiple inflection points over the next 12-18 Months Company's Novel